| T | Act | Project | Year | Sub | Principal Investigator(s)/ Project Leader(s) | Organization | Fiscal Year | Admin IC | Funding IC | FY Total Cost by IC | Similar Projects |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Optimizing the diagnostic approach to cephalosporin allergy testing (DACAT Trial) | |||||||||||
| 1Tf | U01Actf | AI184071Projectf | 01Yearf | BLUMENTHAL, KIMBERLY GOLD | MASSACHUSETTS GENERAL HOSPITAL | 2024 | NIAID | NIAID | $3,234,536 | View View Similar Projects Similar Projectsf | |
| Improving Equitable Access to Penicillin Allergy De-Labeling | |||||||||||
| 5Tf | R01Actf | HS029319Projectf | 04Yearf | BLUMENTHAL, KIMBERLY GOLD | MASSACHUSETTS GENERAL HOSPITAL | 2025 | AHRQ | AHRQ | $249,967 | View View Similar Projects Similar Projectsf | |
| T | Act | Project | Year | Sub | Principal Investigator(s)/ Project Leader(s) | Organization | Fiscal Year | Admin IC | Funding IC | FY Total Cost by IC | Similar Projects |
|---|